Correlation Between IDEXX Laboratories and PharmChem

Can any of the company-specific risk be diversified away by investing in both IDEXX Laboratories and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IDEXX Laboratories and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between IDEXX Laboratories and PharmChem, you can compare the effects of market volatilities on IDEXX Laboratories and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IDEXX Laboratories with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of IDEXX Laboratories and PharmChem.

Diversification Opportunities for IDEXX Laboratories and PharmChem

0.55

Correlation Coefficient

IDEXX Laboratories  PharmChem

Very weak diversification

The 3 months correlation between IDEXX and PharmChem is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding IDEXX Laboratories and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and IDEXX Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IDEXX Laboratories are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of IDEXX Laboratories i.e., IDEXX Laboratories and PharmChem go up and down completely randomly.

Pair Corralation between IDEXX Laboratories and PharmChem

Given the investment horizon of 90 days IDEXX Laboratories is expected to under-perform the PharmChem. But the stock apears to be less risky and, when comparing its historical volatility, IDEXX Laboratories is 1.68 times less risky than PharmChem. The stock trades about -0.13 of its potential returns per unit of risk. The PharmChem is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  362.00  in PharmChem on September 17, 2024 and sell it today you would lose (57.00) from holding PharmChem or give up 15.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.92%
Values	Daily Returns

IDEXX Laboratories  vs.  PharmChem

IDEXX Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

PharmChem

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with IDEXX Laboratories and PharmChem

The main advantage of trading using opposite IDEXX Laboratories and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IDEXX Laboratories position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.

The idea behind IDEXX Laboratories and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.